U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Stat Medical Devices, Inc. - 473754 - 03/28/2018
  1. Warning Letters

CLOSEOUT LETTER

Stat Medical Devices, Inc. MARCS-CMS 473754 —

Recipient:
Stat Medical Devices, Inc.

United States

Issuing Office:

United States

 

   

Black HHS-Blue FDA Logo

 

 
 
555 Winderley Place #200
Maitland, FL 32751
Telephone: (407) 475-4700 

VIA ELECTRONIC MAIL

sschraga@statdevices.com
 

March 28, 2018
 

Mr. Steven Schraga, President
Stat Medical Devices, Inc.
2056 NE 153rd Street
Miami, FL 33162 U.S.A.

RE: Warning Letter Close-Out Letter – FEI 1000525253
CMS Case ID: 473754, CMS WA ID: 144791

Dear Mr. Schraga:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter FLA-15-29, dated July 23, 2015. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Rafael Padilla
Acting Program Division Director
Division of Medical Devices and
Radiological Health Operations II Central

Back to Top